IMMUNO AG has a total of 1,143 patent applications. Its first patent ever was published in 1967. It filed its patents most often in Austria, Canada and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are BAXTER AG, CHEMO SERO THERAPEUT RES INST and CENTEON PHARMA GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Austria | 178 | |
#2 | Canada | 119 | |
#3 | United States | 119 | |
#4 | Japan | 106 | |
#5 | EPO (European Patent Office) | 97 | |
#6 | Germany | 53 | |
#7 | WIPO (World Intellectual Property Organization) | 50 | |
#8 | Finland | 43 | |
#9 | Norway | 39 | |
#10 | Denmark | 37 | |
#11 | Hungary | 37 | |
#12 | Australia | 35 | |
#13 | Czechia | 32 | |
#14 | Spain | 25 | |
#15 | France | 16 | |
#16 | Sweden | 16 | |
#17 | Argentina | 14 | |
#18 | Italy | 13 | |
#19 | Slovakia | 13 | |
#20 | United Kingdom | 12 | |
#21 | Yugoslavia (Serbia and Montenegro) | 12 | |
#22 | Netherlands | 10 | |
#23 | Switzerland | 9 | |
#24 | Poland | 9 | |
#25 | Croatia | 8 | |
#26 | Mexico | 8 | |
#27 | Russian Federation | 5 | |
#28 | Slovenia | 5 | |
#29 | Brazil | 4 | |
#30 | Belgium | 3 | |
#31 | Czechoslovakia | 3 | |
#32 | Israel | 2 | |
#33 | Luxembourg | 2 | |
#34 | USSR (Union of Socialist Soviet Republics) | 2 | |
#35 | South Africa | 2 | |
#36 | China | 1 | |
#37 | German Democratic Republic | 1 | |
#38 | Indonesia | 1 | |
#39 | Ireland | 1 | |
#40 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Medical technology | |
#5 | Foods and drinks | |
#6 | Measurement | |
#7 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Unspecified technologies | |
#6 | Enzymes | |
#7 | Object sterilising | |
#8 | Analysing materials | |
#9 | Climate change adaptation technologies | |
#10 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Eibl Johann | 260 |
#2 | Dorner Friedrich | 193 |
#3 | Linnau Yendra | 154 |
#4 | Eibl Johann Dr | 128 |
#5 | Schwarz Hans-Peter | 96 |
#6 | Schwarz Otto | 83 |
#7 | Linnau Yendra Dr | 81 |
#8 | Turecek Peter | 76 |
#9 | Philapitsch Anton | 67 |
#10 | Seelich Thomas | 48 |
Publication | Filing date | Title |
---|---|---|
JP2000342290A | Polypeptide and preparation of polypeptide | |
ATA98599A | Preparation of recombinant protein, useful for e.g. blood factors, using serum- and protein-free medium supplemented with specific amino acids for increased productivity | |
ATA49899A | Method and device for mixing components | |
ATA803799A | Test kit | |
ATA28399A | Method for producing a vwf preparation | |
ATA27199A | USE OF orosomucoid FOR PRODUCING A PHARMACEUTICAL PREPARATION | |
ATA19499A | Inactivated influenza virus vaccine for nasal or oral application | |
ATA187398A | PHARMACEUTICAL PREPARATION CONTAINING A RECEPTOR ANTAGONIST FOR THE TREATMENT OF BLOOD COagulation disorders | |
ATA155598A | New influence virus vaccine composition | |
ATA109898A | Hepatitis C virus-positive endometrial cell line | |
ATA104398A | Pharmaceutical factor vii preparation | |
ATA96398A | Method for determining antigens | |
ATA86698A | Method for obtaining purified factor viii: c / vwf complex | |
ATA34198A | Method for deploying pathogens from protein-containing solutions | |
ATA5698A | Chimean poxvirus containing a retroviral vector component | |
ATA159397A | Fibrine sponge | |
ATA159497A | Method for purifying antithrombin iii | |
ATA159197A | Pharmaceutical preparation containing vitamin k-dependent individual factors | |
ATA159597A | PREPARATION FOR TREATING BLOOD COagulation disorders | |
ATA159297A | Immunotolerant prothrombin complex preparation |